Corticobasal syndrome as a phenotype of various neurodegenerative disorders: a case series | Zendy

Yu. A. Shpilyukova | Zendy; E. Yu. Fedotova | Zendy; С. Н. Иллариошкин | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Corticobasal syndrome as a phenotype of various neurodegenerative disorders: a case series

Author(s) -

Yu. A. Shpilyukova,

E. Yu. Fedotova,

С. Н. Иллариошкин

Publication year - 2022

Publication title -

annals of clinical and experimental neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.118

H-Index - 2

eISSN - 2409-2533

pISSN - 2075-5473

DOI - 10.54101/acen.2022.1.9

Subject(s) - corticobasal degeneration , frontotemporal dementia , tauopathy , progressive supranuclear palsy , disease , parkinsonism , medicine , dementia , frontotemporal lobar degeneration , clinical phenotype , phenocopy , phenotype , pathology , neuroscience , bioinformatics , neurodegeneration , biology , genetics , gene

Corticobasal syndrome (CBS) is a variant of atypical parkinsonism. The underlying cause may be corticobasal degeneration or other proteinopathies, which can be verified only after studying specific biomarkers. The disease aetiology in CBS needs to be established to determine the disease prognosis. It can also affect the choice of pathogenetic treatment due to the differences in the molecular pathogenesis of proteinopathies that cause neurodegenerative processes. Four clinical cases of CBS are presented: in patients with four-repeat tauopathy, Alzheimer's disease, frontotemporal dementia and CreutzfeldtJakob disease. Examples are provided of the clinical, genetic and biochemical biomarkers available for differential diagnosis of CBS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research